Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 2014

View Archived Issues

Identification of novel antigens for multicomponent malaria vaccines

Aldea Pharmaceuticals closes Series B financing

Reprogramming of porcine ventricular cardiomyocytes to generate a biological pacemaker

Genome-wide copy DNA screening uncovers a novel regulator of brown fat adaptive thermogenesis

Novel series of aldosterone synthase inhibitors discovered at Merck & Co.

NEOMED Institute presents new P2X3 receptor antagonists

New PDE4B inhibitors disclosed by Gruenenthal

Telik receives NCI contract to develop antibody-based PET imaging agent

FDA approves Zorvolex for management of osteoarthritis pain

Novel 5-HT6 receptor agonists show significant efficacy in animal models of cognition

NEOMED Institute receives Canadian government funding

MediciNova cleared to begin clinical study of ibudilast in ALS

Cilag acquires Covagen

Alexion begins trial of eculizumab to prevent delayed graft function after kidney transplantation

La Jolla Pharmaceutical initiates phase I/II trial of LJPC-501 in hepatorenal syndrome

Alkermes files NDA for depot formulation of aripiprazole lauroxil for schizophrenia

Cancer Genetics enters collaboration to discover diffuse large B-cell lymphoma markers

Findings from preclinical study of DepoVax-formulated vaccine for Ebola

NFkB decoy oligonucleotide moves to phase III study in atopic dermatitis

Roche to acquire InterMune

FDA approves Triumeq for HIV

OncoSynergy plans study of anticancer MAb in Ebola virus infection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...